Jagsonpal Pharma

{
  "main_header": {
    "sid": 134241,
    "name": "Jagsonpal Pharma",
    "stock_name": "Jagsonpal Pharma",
    "full_name": "Jagsonpal Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/jagsonpal-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "231.21",
    "chg": -6.84,
    "chgp": "-2.87%",
    "dir": -1,
    "prev_price": "238.05",
    "mcapval": "1,575.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 507789,
    "symbol": "JAGSNPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE048B01035",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "22:08 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "74.93 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/jagsonpal-pharma-134241-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4144121",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_mojoScore_4144121.png",
        "date": "2026-08-09 10:10:04",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-signal-bullish-outlook-4132772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/JagsonpalPharma_technicaldot_4132772.png",
        "date": "2026-08-03 08:00:17",
        "description": "Jagsonpal Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a more confident bullish trend. Despite a recent day decline of 2.68%, the stock’s underlying technical parameters suggest improving momentum that could influence investor sentiment in the coming weeks."
      },
      {
        "title": "Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-jagsonpal-pharmaceuticals-ltd-latest-results-good-or-bad-4129032",
        "imagepath": "",
        "date": "2026-07-30 19:18:55",
        "description": "Jagsonpal Pharmaceuticals Ltd has reported its financial results for Q1 FY27, showcasing notable operational trends. The company achieved a record quarterly revenue of ₹82.23 crores, reflecting a sequential growth of 28.08% compared to the previous quarter. Year-on-year revenue growth was recorded at 8.76%, indicating steady market expansion despite competitive pressures.\n\nNet profit for the quarter stood at ₹13.19 crores, which represents a significant quarter-on-quarter increase of 50.56% and a year-on-year growth of 22.13%. The improvement in profitability is further underscored by an operating margin that expanded to 20.97%, up from 17.38% in the previous quarter, highlighting effective cost management and a favorable product mix.\n\nThe company's return on equity (ROE) is reported at 17.66%, which is above its five-year average, suggesting effective management in generating returns for shareholders. Addi..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Q1 FY27: Strong Quarter Marred by Expensive Valuation",
        "link": "https://www.marketsmojo.com/news/result-analysis/jagsonpal-pharmaceuticals-q1-fy27-strong-quarter-marred-by-expensive-valuation-4128796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JagsonpalPharma_quaterlyResult_4128796.png",
        "date": "2026-07-30 10:01:30",
        "description": "Jagsonpal Pharmaceuticals Ltd. reported a robust first quarter for FY2027, with net profit surging 50.56% quarter-on-quarter to ₹13.19 crores, marking the company's strongest quarterly performance in recent history. The micro-cap pharmaceutical manufacturer, with a market capitalisation of ₹1,651.86 crores, saw its stock rally 8.70% following the results announcement, closing at ₹250.55 on July 30, 2026. However, despite the impressive operational performance, the company's valuation remains stretched at 34 times trailing earnings, raising questions about sustainability of current price levels."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-4125696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JagsonpalPharma_mojoScore_4125696.png",
        "date": "2026-07-29 10:11:32",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "When is the next results date for Jagsonpal Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-jagsonpal-pharmaceuticals-ltd-4118304",
        "imagepath": "",
        "date": "2026-07-23 23:16:51",
        "description": "The next results date for Jagsonpal Pharmaceuticals Ltd is scheduled for July 29, 2026...."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-sell-4106980",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JagsonpalPharma_mojoScore_4106980.png",
        "date": "2026-07-18 10:10:36",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/jagsonpal-pharmaceuticals-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4091655",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JagsonpalPharma_mojoScore_4091655.png",
        "date": "2026-07-07 08:21:19",
        "description": "Jagsonpal Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a combination of deteriorating financial trends, expensive valuation metrics, and a shift in technical indicators. Despite some long-term outperformance relative to the Sensex, recent quarterly results and technical signals have prompted a reassessment of the stock’s outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4091158",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JagsonpalPharma_technicaldot_4091158.png",
        "date": "2026-07-07 08:00:21",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a modest day gain of 0.36%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the recent technical developments, placing them in the context of the company’s price performance and broader market trends."
      }
    ],
    "total": 278,
    "sid": "134241",
    "stock_news_url": "https://www.marketsmojo.com/news/jagsonpal-pharmaceuticals-134241"
  },
  "announcements": [
    {
      "details": "Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr ASHOK KUMAR PATI as Additional Non-Executive Independent Director of the company w.e.f. November 14, 2019.",
      "source": "NSE",
      "caption": "Jagsonpal Pharmaceuticals Limited - Appointment",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Jagsonpal Pharmaceuticals Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Jagsonpal Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "19-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>125%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25",
          "dt": "2025-01-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Jagsonpal Pharmaceuticals Ltd is Rated Hold

2026-08-09 10:10:04

Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook

2026-08-03 08:00:17

Jagsonpal Pharmaceuticals Ltd has witnessed a notable shift in its technical momentum, with key indicators signalling a transition from a mildly bullish to a more confident bullish trend. Despite a recent day decline of 2.68%, the stock’s underlying technical parameters suggest improving momentum that could influence investor sentiment in the coming weeks.

Read full news article

Are Jagsonpal Pharmaceuticals Ltd latest results good or bad?

2026-07-30 19:18:55

Jagsonpal Pharmaceuticals Ltd has reported its financial results for Q1 FY27, showcasing notable operational trends. The company achieved a record quarterly revenue of ₹82.23 crores, reflecting a sequential growth of 28.08% compared to the previous quarter. Year-on-year revenue growth was recorded at 8.76%, indicating steady market expansion despite competitive pressures. Net profit for the quarter stood at ₹13.19 crores, which represents a significant quarter-on-quarter increase of 50.56% and a year-on-year growth of 22.13%. The improvement in profitability is further underscored by an operating margin that expanded to 20.97%, up from 17.38% in the previous quarter, highlighting effective cost management and a favorable product mix. The company's return on equity (ROE) is reported at 17.66%, which is above its five-year average, suggesting effective management in generating returns for shareholders. Addi...

Read full news article

Jagsonpal Pharmaceuticals Q1 FY27: Strong Quarter Marred by Expensive Valuation

2026-07-30 10:01:30

Jagsonpal Pharmaceuticals Ltd. reported a robust first quarter for FY2027, with net profit surging 50.56% quarter-on-quarter to ₹13.19 crores, marking the company's strongest quarterly performance in recent history. The micro-cap pharmaceutical manufacturer, with a market capitalisation of ₹1,651.86 crores, saw its stock rally 8.70% following the results announcement, closing at ₹250.55 on July 30, 2026. However, despite the impressive operational performance, the company's valuation remains stretched at 34 times trailing earnings, raising questions about sustainability of current price levels.

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-07-29 10:11:32

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Jul 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 29 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

When is the next results date for Jagsonpal Pharmaceuticals Ltd?

2026-07-23 23:16:51

The next results date for Jagsonpal Pharmaceuticals Ltd is scheduled for July 29, 2026....

Read full news article

Jagsonpal Pharmaceuticals Ltd is Rated Sell

2026-07-18 10:10:36

Jagsonpal Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Jagsonpal Pharmaceuticals Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-07-07 08:21:19

Jagsonpal Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell, reflecting a combination of deteriorating financial trends, expensive valuation metrics, and a shift in technical indicators. Despite some long-term outperformance relative to the Sensex, recent quarterly results and technical signals have prompted a reassessment of the stock’s outlook.

Read full news article

Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-07-07 08:00:21

Jagsonpal Pharmaceuticals Ltd has experienced a subtle shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a modest day gain of 0.36%, the stock’s technical indicators present a nuanced picture, with some metrics signalling strength while others suggest caution. This article analyses the recent technical developments, placing them in the context of the company’s price performance and broader market trends.

Read full news article

View All News